Recordati Rare Diseases anuncia la publicación de los resultados a largo plazo de la extensión del estudio de fase III LINC 3 de Isturisa® (osilodrostat) en pacientes con enfermedad de Cushing en The European Journal of Endocrinology - Iberonews iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.
The LINC 4 study demonstrated superiority of Isturisa (osilodrostat) over placebo in achieving cortisol normalisation during the 12-week, double-blind, randomised phase (77% vs 8%, P Isturisa provided
Recordati Rare Diseases anuncia la publicaci贸n en el Journal of Clinical Endocrinology & Metabolism del estudio de fase III LINC 4 que confirma la eficacia y seguridad de Isturisa庐 (osilodrostat) en pacientes con enfermedad de Cushing - Iberonews iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.
Gedeon Richter: Cariprazine is well tolerated in the early stage of schizophrenia and has a positive effect on engagement compared to another antipsychotic
Between the 10-13 was held virtually due to the COVID-19 pandemic situation - new analysis of cariprazine studies with patients experiencing acute or predominant negative symptoms (PNS) of schizophrenia was presented by Gedeon Richter Plc. According to the scientific posters, cariprazine significantly improved patient engagement in individuals suffering from PNS compared to risperidone, and the co-administration of cariprazine with other antipsychotic medications did not show an unexpected safety profile nor overlapping toxicities. It was also shown that cariprazine was well-tolerated in the early stage of the illness (first five years) and the discontinuation rates due to unbearable side effects were also low.
RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4 STUDY PRESENTED AT THE ENDOCRINE apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.